Nanoform and Revio Therapeutics have entered into a collaboration to develop GLIORA, a nanoformulated hydrogel for local and long-acting treatment of high-risk glioma. Using Nanoform's patented CESS technology and a...
You need to create a user account to read this article.
With a subscription you unlock more content on BioStock.